Sodium Tanshinone IIA Sulfonate Enhances Effectiveness Rt-PA Treatment in Acute Ischemic Stroke Patients Associated with Ameliorating Blood-Brain Barrier Damage. - Wikidata - wikimedia - TriplyDB

Sodium Tanshinone IIA Sulfonate Enhances Effectiveness Rt-PA Treatment in Acute Ischemic Stroke Patients Associated with Ameliorating Blood-Brain Barrier Damage.

Sodium Tanshinone IIA Sulfonate Enhances Effectiveness Rt-PA Treatment in Acute Ischemic Stroke Patients Associated with Ameliorating Blood-Brain Barrier Damage.

http://www.wikidata.org/entity/Q33861317

about

β2-Adrenergic Receptor-Mediated HIF-1α Upregulation Mediates Blood Brain Barrier Damage in Acute Cerebral Ischemia.Tanshinone IIA Sodium Sulfonate Attenuates LPS-Induced Intestinal Injury in Mice.Tight junction structure, function, and assessment in the critically ill: a systematic review

P2860

Q41430066-39F8021E-4D84-4E32-B893-32731176C10E Q53070545-5190E9CA-ED1C-4C1F-91AC-AC02B32972AF Q58695844-8D378ABA-DB5C-4ABC-BEA5-9A349E64890D

P2860

Sodium Tanshinone IIA Sulfonate Enhances Effectiveness Rt-PA Treatment in Acute Ischemic Stroke Patients Associated with Ameliorating Blood-Brain Barrier Damage.

http://www.wikidata.org/entity/Q33861317

description

2017 nî lūn-bûn

@nan

2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Sodium Tanshinone IIA Sulfonat ...... ng Blood-Brain Barrier Damage.

@ast

Sodium Tanshinone IIA Sulfonat ...... ng Blood-Brain Barrier Damage.

@en

type

label

Sodium Tanshinone IIA Sulfonat ...... ng Blood-Brain Barrier Damage.

@ast

Sodium Tanshinone IIA Sulfonat ...... ng Blood-Brain Barrier Damage.

@en

prefLabel

Sodium Tanshinone IIA Sulfonat ...... ng Blood-Brain Barrier Damage.

@ast

Sodium Tanshinone IIA Sulfonat ...... ng Blood-Brain Barrier Damage.

@en

P1433

Q33861317-311A502C-78BC-4288-8792-A0FF9A41CB40

P1476

Q33861317-90711DDF-CC86-4208-94CC-44C755812D72

P2093

Q33861317-067E75B8-2013-4445-95D4-1AC43F97CD49

Q33861317-25A861FA-98CD-4A82-92D1-245F741BEE0A

Q33861317-37866EF1-3FC0-4916-8EA4-9B28DAF533F7

Q33861317-3D312F97-59E8-439F-AC75-6A720E632C95

Q33861317-4C13DDB1-8FB5-4F01-A20D-ABC38E4877E8

Q33861317-4D220B92-E580-4E97-9274-B9EBB07C4B3C

Q33861317-70C86DD5-F1B6-4944-9301-26B131F42394

Q33861317-84CD1B53-E56D-4C12-B780-B8957C80C1FE

Q33861317-BCBAD10C-C623-47A4-AB69-498DB61C94C5

Q33861317-C5C4FFB8-C3AE-486A-B245-D1BE4FB8ECE7

P2860

Q33861317-19A1E991-3B65-426D-8B11-69836A132FFA

Q33861317-2062DB37-587C-4C26-A8AA-AE8606850E51

Q33861317-570FDF77-AD7E-4029-B9B6-6AED7C9D864F

Q33861317-5D31E86D-0D3E-4C59-90DC-CCF2DAEDFBE2

Q33861317-6CA9C76B-34EE-4E01-9D30-5407E7331DB9

Q33861317-771E7774-0672-4240-8D74-6ACA15124226

Q33861317-8C452C13-820A-44C9-A0CA-397139BE3993

Q33861317-8E337FD7-752B-4E04-AE12-0629B18562B2

Q33861317-9644A055-4E3D-4701-9A84-66E7718AC9F9

Q33861317-99453A57-AE55-4E9E-8C5B-1F4CA74E50C7

P2888

Q33861317-AA5350F4-5854-48C0-AF92-A9B86670A0FA

P304

Q33861317-D7AEA784-BE2E-46E6-88D7-C07D0FFAC5AC

P31

Q33861317-05692320-B6D7-4E1D-AB0A-5F5D6F3CF22D

P356

Q33861317-F4712D27-9F89-425C-986B-197265DECF58

P433

Q33861317-4627A8A9-F976-40B8-8231-2154799D2850

P478

Q33861317-0D68D1BA-F95C-4C9A-9830-043D9DF9B587

P577

Q33861317-25DF298D-5A2D-4F82-ADD3-E419AA3221AC

P6179

Q33861317-B1AB3B43-7F90-4BCC-B7A0-5C0C6C818DE8

P698

Q33861317-2FB88A01-965C-4328-9A44-0544F3172C2B

P921

Q33861317-B01442BD-BDB9-4C0B-B835-3513A6BAEAC5

P932

Q33861317-DA7661E9-88FB-4960-A6F1-0C40BD0CAF76

P356

S12975-017-0526-6

P1433

Translational stroke research

P1476

Sodium Tanshinone IIA Sulfonat ...... ng Blood-Brain Barrier Damage.

@en

P2093

Biying Ji

http://www.w3.org/2001/XMLSchema#string

Fei Zhou

http://www.w3.org/2001/XMLSchema#string

Haijian Fan

http://www.w3.org/2001/XMLSchema#string

Jingwei Li

http://www.w3.org/2001/XMLSchema#string

Jun Yang

http://www.w3.org/2001/XMLSchema#string

Lijuan Han

http://www.w3.org/2001/XMLSchema#string

Shanshan Li

http://www.w3.org/2001/XMLSchema#string

Xiangyan Chen

http://www.w3.org/2001/XMLSchema#string

Xiaoying Wang

http://www.w3.org/2001/XMLSchema#string

Xin Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

Tanshinone II A down-regulates HMGB1, RAGE, TLR4, NF-kappaB expression, ameliorates BBB permeability and endothelial cell function, and protects rat brains against focal ischemia

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

Evaluating blood-brain barrier permeability in delayed cerebral infarction after aneurysmal subarachnoid hemorrhage.

Translational Stroke Research on Blood-Brain Barrier Damage: Challenges, Perspectives, and Goals.

The Effect of Sodium Tanshinone IIA Sulfate and Simvastatin on Elevated Serum Levels of Inflammatory Markers in Patients with Coronary Heart Disease: A Study Protocol for a Randomized Controlled Trial.

Relation between stroke severity, patient characteristics and CT-perfusion derived blood-brain barrier permeability measurements in acute ischemic stroke.

Mmp-9 inhibition: a therapeutic strategy in ischemic stroke.

Tanshinone derivatives: a patent review (January 2006 - September 2012).

Blood-brain barrier permeability imaging using perfusion computed tomography

P2888

s12975-017-0526-6

P304

334-340

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12975-017-0526-6

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084036369

http://www.w3.org/2001/XMLSchema#string

P698

28243834

http://www.w3.org/2001/XMLSchema#string

P921

blood–brain barrier

P932

5493726

http://www.w3.org/2001/XMLSchema#string